Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 17/20 | 0.39 |
| ▸ | SLC5A1 | P13866 | 9/20 | 0.39 |
| ▸ | CCR5 | P51681 | 1/20 | 0.37 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17483 | 0.95 | SLC5A2 (0.40) | SLC5A2SLC5A1CCR5 | |
| SCHEMBL18722 | 0.87 | CCR5 (0.37) | SLC5A2SLC5A1CCR5SCN9A | |
| SCHEMBL18062 | 0.82 | CCR5 (0.39) | SLC5A2SLC5A1CCR5SCN9A | |
| SCHEMBL17334 | 0.81 | SLC5A2 (0.38) | SLC5A2SLC5A1 | |
| SCHEMBL18040 | 0.80 | SLC5A2 (0.45) | SLC5A2SLC5A1 | |
| SCHEMBL18072 | 0.79 | HPGD (0.46) | SLC5A2SLC5A1 | |
| SCHEMBL23912 | 0.78 | SLC5A2 (0.38) | SLC5A2SLC5A1 | |
| SCHEMBL14954721 | 0.78 | PPARA (0.39) | SLC5A2SLC5A1CCR5 | |
| SCHEMBL17356 | 0.77 | SLC5A2 (0.38) | SLC5A2SLC5A1 | |
| SCHEMBL17831 | 0.77 | SLC5A2 (0.43) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012025857-A1 | CYCLOALKYL METHOXYBENZYL PHENYL PYRAN DERIVATIVES AS SODIUM DEPENDENT GLUCOSE CO TRANSPORTER (SGLT2) INHIBITORS | HETERO RESEARCH FOUNDATION (IN) | 2012-03-01 | — | — | WO | disclosed |
| WO-2012025857-A1 | CYCLOALKYL METHOXYBENZYL PHENYL PYRAN DERIVATIVES AS SODIUM DEPENDENT GLUCOSE CO TRANSPORTER (SGLT2) INHIBITORS | HETERO RESEARCH FOUNDATION (IN) | 2012-03-01 | — | — | WO | disclosed |